Efficacy and safety of inhaled human insulin (Exubera®) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: Results of a 3-month, randomized, parallel trial
Neil H. White, Teresa Quattrin, Lisa B. St. Aubin, William T. Duggan, Richard D. England, Julie S. Fryburg
Dive into the research topics of 'Efficacy and safety of inhaled human insulin (Exubera®) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: Results of a 3-month, randomized, parallel trial'. Together they form a unique fingerprint.